Tag: Sophie Shi
Han Kun, Zhong Lun act on Sino Biopharm’s USD950m LaNova buy
Han Kun and Zhong Lun advised on Sino Biopharm’s USD950m acquisition of cancer drugmaker LaNova Medicines
LATEST ON LAW.ASIA
ANI v OpenAI ruling: Reading the tea leaves
In-house legal teams that adapt now will be better placed for the final judgment after the first ruling on AI training and copyright
MOST READ ON LAW.ASIA
Going ‘AI-native’
Veteran counsel, tech CEO unpack ‘AI-native’ legal adoption
